Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

We compared adjuvant chemotherapy-related myocardial damage by antimyosin scintigraphy in patients who received either nine cycles of FEC (fluorouracil, epirubicin and cyclophosphamide) where the doses of epirubicin and cyclophosphamide were escalated according to the leucocyte nadir (group I, n = 1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Erselcan, T, Kairemo, K J A, Wiklund, T A, Hernberg, M, Blomqvist, C P, Tenhunen, M, Bergh, J, Joensuu, H
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2000
Soggetti:
Regular Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374396/
https://ncbi.nlm.nih.gov/pubmed/10732745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.0998
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi